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Abstract
Background: Although the study of research utilization is not new, there has been increased
emphasis on the topic over the recent past. Science push models that are researcher driven and
controlled and demand pull models emphasizing users/decision-maker interests have largely been
abandoned in favour of more interactive models that emphasize linkages between researchers and
decisionmakers. However, despite these and other theoretical and empirical advances in the area
of research utilization, there remains a fundamental gap between the generation of research
findings and the application of those findings in practice.
Methods:  Using a case approach, the current study looks at the impact of one particular
interaction approach to research translation used by a Canadian funding agency.
Results:  Results suggest there may be certain conditions under which different levels of
decisionmaker involvement in research will be more or less effective. Four attributes are
illuminated by the current case study: stakeholder diversity, addressability/actionability of results,
finality of study design and methodology, and politicization of results. Future research could test
whether these or other variables can be used to specify some of the conditions under which
different approaches to interaction in knowledge translation are likely to facilitate research
utilization.
Conclusion: This work suggests that the efficacy of interaction approaches to research translation
may be more limited than current theory proposes and underscores the need for more completely
specified models of research utilization that can help address the slow pace of change in this area.
Background
There has been increased emphasis on the topic of
research utilization over the recent past [1-5]. Research
utilization, discussed more now in the context of knowl-
edge translation, has also become a priority for healthcare
research funding bodies internationally [6], the UK's Med-
ical Research Council, and one Canadian research founda-
tion has dedicated itself to knowledge transfer [7]. Science
push models that are researcher driven and controlled and
demand pull models emphasizing users/decisionmaker
interests have largely been abandoned in favour of more
interactive models that emphasize linkages between
researchers and decisionmakers [8]. However, despite
these and other theoretical and empirical advances in the
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area of research utilization, there remains a fundamental
gap between the generation of research findings and the
application of those findings in practice. In order to begin
filling this gap, we build on work that recognizes that
research findings are used in many ways and have multi-
ple effects [9-11]. Using a case approach, the current study
looks at the impact of one particular interaction approach
to knowledge translation used by a Canadian funding
agency. By specifying some of the conditions under which
different levels of decisionmaker involvement in research
might be more or less effective, this work suggests that the
efficacy of interaction approaches to research translation
may apply to more limited contexts than what is pre-
scribed by current theory. Note that the terms research uti-
lization, knowledge utilization and knowledge
translation are used throughout this paper in keeping with
the terminology used by the authors we cite. These proc-
esses are roughly equivalent though RU is sometimes seen
as narrower than KT. In this paper we are referring to the
process whereby research is transferred and used (either
instrumentally, conceptually or symbolically, read further
for an explanation of these terms).
While the area of knowledge translation extends well
beyond the life of any given study [7], ensuring that find-
ings from certain individual research studies have an
impact remains an important area for research. Our
review of the literature focuses on what is known about
effective approaches to research utilization, and we draw
on the broader field of knowledge translation and the
organizational literature to the extent that findings in
these areas add additional insight.
Landry, et al. describe several models of knowledge utili-
zation including the push model (emphasizing research
production), the pull model (marked by user driven
research), and the dissemination model that focuses on
the dissemination effort itself [8]. The fourth model they
describe, the interaction model, is said to successfully
address the shortcomings of the other three models and
proposes a linkage variable or mechanism that brings
researchers and decisionmakers together throughout the
research process. Landry et al. suggest that "the more
resources the researchers invest in these types of linkage
mechanisms, the higher the use of social science research"
[8]. Indeed, the absence of interactions between research-
ers and decisionmakers has been cited as the primary rea-
son for low utilization of research findings [12], and
interaction approaches to research utilization are per-
ceived to be the most valuable approaches by decision-
makers according to a recent systematic review [13].
In terms of the nature of researcher-decisionmaker inter-
actions, the literature highlights the importance of face-to-
face contact and interaction through forums that bring
researchers and decisionmakers together to facilitate inter-
pretation of research results [5,14,15]. In the organiza-
tional literature, joint interpretive forums to discuss and
interpret study results were shown to have a positive rela-
tionship to the perceived usefulness of a research project
[4]. More general forums for sharing research knowledge
have also been proposed as one element of a 'communi-
cative perspective' on research collaboration [16].
The literature is also fairly definite on the span or duration
of these interactions. Lomas notes that "the clearest mes-
sage from evaluation of successful research utilization is
that early and ongoing involvement of relevant decision-
makers in the conceptualization and conduct of a study is
the best predictor of its utilization" [17]. The importance
of involvement beginning in the initial stages of a research
study (e.g. the development of research questions) is cen-
tral to participatory and community based research [18]
and other work on researcher-decisionmaker interactions
in healthcare [15,19] and education [14]. The presence of
a historical or longstanding relationship between
researchers and decisionmakers, where research utiliza-
tion is only one activity in a larger, ongoing relationship,
has been identified as important for the utilization of
research findings [1,4,7,16]. This is consistent with politi-
cal science and sociological perspectives, with the organi-
zational literature, and work in the larger field of
knowledge translation and knowledge creation, suggest-
ing that both research utilization and knowledge transla-
tion are highly social processes that are more successful in
the presence of positive social interactions between com-
munities [3,20,21].
In fact, it is often suggested that relationships and face-to-
face contact are more important to effective research utili-
zation than the quality, methods, content of a research
study, or its 'fit' with a decisionmaker's expressed need for
the research [8,11]. This has to do with the fact that the
determinants of research utilization are often organiza-
tional or political [22], and only rarely rational [17]. Two
recent empirical studies found that interaction between
researchers and decisionmakers, which began at the plan-
ning stage of a study, did not influence utilization of study
results. Interestingly, in one of the studies this occurred
because study findings were in conflict with decision-
maker's organizational and political interests [22]. In the
other study, where findings confirmed existing practice,
applied use was found to occur equally across groups that
were involved in the planning and interpretation of the
research and groups that were not involved [23]. These
observations are entirely consistent with literature on the
use of information in decision-making in the organiza-
tional literature [24-26]. For instance, information or
research findings that are consistent with our values or
expectations tend to be accepted, while information thatImplementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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is inconsistent tends to be challenged, questioned, and
ultimately disregarded [22,27]. Accordingly, it has been
argued that the importance of alignment between research
findings and institutional context should not be underes-
timated [28,29].
Ross, et al., in their qualitative study of researcher-deci-
sionmaker partnership experiences, broaden our under-
standing of the nature of decisionmaker involvement in
research by articulating three models: first, formal support
– where decisionmakers explicitly support, facilitate
access to resources, and confer legitimacy on the research
but do not get involved in the research process; second,
responsive audience – where decisionmakers provide
information, respond to researchers' queries and informa-
tion needs, and are involved in most phases of the
research process beyond conceptualization; and third
integral partner – where there is a high degree of decision-
maker initiated contact and the decisionmaker is fully
engaged as a significant partner, including in the concep-
tualization phase [2]. They also suggest four factors that
influence the decisionmaker's role (stage of research proc-
ess, time commitment required, alignment between deci-
sionmaker expertise and research program, presence of an
existing relationship). Their work provides a valuable
starting point for considering how and when to best inter-
twine the research and decision-making processes.
Although interaction models of research utilization that
bring researchers and decisionmakers together is one of
the dominant models for promoting research utilization,
there is little in the published literature about the condi-
tions under which various interactive approaches are
more or less successful. In addition, the literature is silent
on the role of variation in the nature/attributes of
research. For instance, does highly politicized or publi-
cized research warrant different forms of interaction?
Does descriptive research that provides evidence of prob-
lems require different or more interaction than interven-
tion research that provides actionable evidence and
solutions? Put differently, perhaps the nature of the
research (e.g., certain attributes such as study politiciza-
tion or stakeholder diversity) moderates the relationship
between interaction and research utilization. In addition,
the literature suggests that where there is decisionmaker
involvement in research, decisionmakers should be
included at all stages of the research process. However,
early and sustained interaction can be onerous and costly,
and it is not clear from the literature whether there may in
fact be some cases where decisionmaker involvement is
most appropriate only at the interpretation and dissemi-
nation stage (e.g., a retreat to older dissemination mod-
els). By looking at the impact and use of research findings
by a heterogeneous group of decisionmakers for a specific,
fairly publicized health services research initiative, our
study provides some insights into these important areas.
When we judge the 'impact and use' of research findings
in this paper, we do so in the context of work which out-
lines different kinds of research utilization. The utilization
of research findings can be instrumental (a concrete appli-
cation of research findings to make specific decisions or
changes) and/or conceptual (e.g., change people's way of
thinking) [9]. In addition, research can be utilized for
more symbolic (e.g., political) purposes [10]. Indeed, the
decision-making literature has documented the same uses
for various kinds of information in the decision-making
process [30]. Conceptual utilization is akin to the kind of
"socialization" that Nonaka and Takeuchi [31] discuss as
one way to convert or transfer tacit knowledge (knowl-
edge that is difficult to formalize and communicate). In
this process, socialization involves the exchange of tacit
knowledge through joint, face-to-face activities "in order
to produce some form of shared mental model... that can
serve as a framework for moving forward" [5]. Landry et
al. [8] suggest there is a need to look beyond narrow
instrumental uses of knowledge, and Estabrooks [32]
argues that the more indirect conceptual and symbolic
uses for research are indeed an important and empirically
demonstrated part of research utilization. Early work in
this area suggests that symbolic use of research is far more
common than instrumental use, which tends to be rare
[33]. That research can be used in any or all of these three
ways is consistent with the ideas that research and knowl-
edge produce multiple effects rather than a single effect
[11] and the utilization of research is therefore a process
rather than a single event [29].
Methods
In 2002, nearly $1 million was granted for the Canadian
Adverse Events Study (CAES) [34]. The objective of CAES
was to report on the incidence of adverse events in Cana-
dian acute care hospitals based on a methodology used in
similar studies in Australia [35] and elsewhere [36,37].
Although other international studies using the Australian
methodology had fairly consistently demonstrated that
roughly 10% of all hospital admissions resulted in an
adverse event, approximately 50% of which were prevent-
able, it was felt that Canadian data were needed to propel
patient safety improvement activities in Canadian hospi-
tals. In 2000, one of the agencies that funded CAES
adopted knowledge translation as one of its priorities.
Given the expected magnitude of the CAES findings, the
agency undertook a knowledge translation effort of their
own to try to generate a proactive response to CAES by a
wide variety of national stakeholders. This effort involved
holding two in-person forums on CAES while the study
was being conducted and two web conferences, the first
one four months prior to release of the study results, andImplementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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the second one immediately prior to release. The agendas
for the forums and web conferences focused on sharing
results of various international studies CAES was trying to
replicate, providing detailed methodology that would be
used in CAES, holding break out group discussions about
safety initiatives, and discussing media preparation for the
CAES release. A diverse, national group of stakeholders
was invited to attend the forums and web conferences
including representatives from federal and provincial
health ministries, professional organizations representing
Canadian physicians and nurses, regulatory colleges gov-
erning various health professions, organizations servicing
hospitals such as Canadian blood services, organizations
representing health facilities and health executives, and
safety-focused organizations such as the Institute for Safe
Medication Practices Canada. To reiterate, the primary
goal of the forums, was to stimulate proactive, instrumen-
tal use [10] of the CAES data as defined above.
We used a single case study approach, with embedded
units, to assess the impact of this knowledge translation
strategy. A case study design [38] was appropriate given
our interest in learning not only about whether this
knowledge translation strategy facilitated a response to
CAES data, but also how it may have facilitated a response
[39]. According to Yin, a case study "investigates a con-
temporary phenomenon within its real-life context, espe-
cially [suitable] when the boundaries between
phenomenon and context are not clearly evident" [38]. In
the present study, the case design permits the develop-
ment of analytical insights where empirical results from
the study can be used to support and inform theory–in
this case related to models of effective decisionmaker
involvement in research. Our approach is consistent with
case study methods used in medicine and the social sci-
ences [38,40].
The knowledge translation strategy–two forums and two
webconferences–(hereafter referred to as "the forums")
constitutes the case and data reported here are based on:
semi-structured interviews conducted with forum partici-
pants, members of CAES research team, and organizers of
the forums; observation of the forums and web confer-
ences; and in-depth study of three of the stakeholder
organizations embedded in the forum case. These three
organizations, including a hospital, a representative
organization for hospitals and health regions (with no
official power), and an accreditation body, were chosen
for their diversity with the idea that the forum process
may impact different stakeholders in different ways.
Data Collection
Semi-structured interviews were carried out with a ran-
dom sample of forum stakeholders following the first
forum held in June 2002, the second forum held in May
2003, and one month prior to release of CAES study
results in May 2004. Following each forum, stakeholders
who attended were grouped according to organization
type (see Table 1) and one stakeholder from each category
was randomly selected to complete an interview. Mem-
bers of the CAES research team who attended the first
forum were contacted for an interview following that
forum, and all CAES researchers were contacted for an
interview prior to the release of CAES. Interviews were
also conducted with individuals in the two sponsor organ-
izations that, together, funded CAES, planned, and hosted
the forums. For the three organizations we studied in-
depth, we visited the organization following each of the
two forums, conducted two to three interviews with indi-
viduals involved in patient safety, and reviewed relevant
documents outlining any patient safety initiatives.
Study interviews were conducted in person or over the tel-
ephone, depending on distance, by the principal investi-
gator or the research assistant. In-person interviews lasted
approximately 60 minutes and were recorded and tran-
scribed. Telephone interviews lasted 30 to 45 minutes and
relied on detailed field notes for analysis. Subjects were
asked why they attended the forum, what they took away
from the meeting, and whether they left feeling there was
something more their organization could be doing in the
area of patient safety. They were also asked to describe
Table 1: Forum Stakeholder Organization Categories
Organization Category # represented 
at forum 1
# represented 
at forum 2
Examples
Professional 5 9 Canadian Medical Association
Service 6 4 Canadian Blood Services
Government 8 12 Saskatchewan Health, Health Canada
Organizational/Management Rep 5 10 Canadian Healthcare Association, Canadian College of Health 
Service Executives
Safety Focused 3 6 Institute for Safe Medication Practices, Canada
Representing other aspects of the health system 4 10 Consumers' Association of Canada
Other 5 11 Canadian Council for Health Services Accreditation
Total # of Organizations Represented 36 62Implementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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major patient safety initiatives in their organization and
comment on the extent to which the forums may have
played a role in their initiation. Ample opportunity for
unstructured responses was provided.
Analysis
All transcripts and field notes were coded using NVivo
(2000). Coding was carried out with the original research
questions in mind–the research questions guided a tem-
plate analysis. Template analysis lies between content
analysis where nodes are predetermined, and grounded
theory where there are no predetermined nodes [41]. It is
important to note that we were studying a researcher-deci-
sionmaker interaction process that was unfolding as we
were studying it–decisions about whether there would be
in-person forums, web conferences, how many and when
they would take place were made from one event to the
next. Accordingly, the nature and timing of data collec-
tion, to some extent, had to emerge in response to forum
activity. Following the two in-person forums we saw nei-
ther a high degree of explicit stakeholder response nor evi-
dence of variation in responses by different stakeholders,
including for the three organizations we were studying in-
depth. Therefore, contrary to what we initially anticipated,
a sub-analysis regarding whether the forums had a differ-
ent impact on different kinds of stakeholders was not car-
ried out.
Results
In total, 33 interviews were conducted over the study
period, 19 with stakeholders, 11 with researchers, and
three with forum organizers. Of the stakeholders and
researchers who were sampled systematically, 74% of the
stakeholders randomly selected for an interview agreed to
conduct an interview (nine of the ten stakeholders con-
tacted following the first forum, and eight of 13 contacted
following the second forum), and six of the eight research-
ers (75%) who attended the first forum agreed to be inter-
viewed. Stakeholders who declined to participate in an
interview tended to feel their organization was peripher-
ally related to CAES, "since [organization name] is very
much a peripheral stakeholder, I am sure that you would
find the comments of other organizations to be far more
relevant" (service organization stakeholder). Ten addi-
tional interviews were conducted using the more purpose-
ful sampling approach described in the methods section:
two additional stakeholders from the organizations we
studied in a more in-depth fashion were interviewed prior
to the release of CAES, five researchers who had some pol-
icy contact prior to release of CAES results were inter-
viewed, and three of the individuals involved with
designing and hosting the forums were interviewed.
Together, the systematic and purposive sampling
approaches yielded data from 33 interviews. The follow-
ing three themes emerged from our analysis of these data.
As noted, these themes were reflected across the diverse
group of stakeholders that took part in the forum process.
We have used quotes from study participants to help illus-
trate these themes [41].
Forums promoted information sharing, discussion and 
networking, and consciousness-raising
The forums were perceived by respondents as being suc-
cessful at informing stakeholders about CAES, as well as
about other studies on the incidence of adverse events that
have been conducted internationally. Our data also sug-
gest that the forums contributed to broader learning
about patient safety, "There was a real recognition that we
are talking about something more than one clinician,
there are bigger system issues that need to be looked at
and how the management and the executives within those
organizations can help, can find out specifically what
those issues are and how they can start to move on them"
(stakeholder, following the first forum). Some stakehold-
ers were critical of the forum process for being too
researcher driven with little room for input (methodolog-
ical and otherwise) from stakeholders, "there was a kind
of command and control feel to it and what we needed
was more of a participative, action approach going for-
ward". Others identified a more bidirectional nature of
the forum exchange, "the forums provided an opportunity
for researchers to see and hear contextual issues in the
environment as they are framing up their research"..
The forums provided opportunities for stakeholders to
network with one another and find out what others were
doing in the area of patient safety–people seemed to find
value in knowing what others were doing and used that
information as a gauge for where their organization
should be. The forums also stimulated discussion that
lasted beyond the forums. One stakeholder noted that,
"in our organization we have now tried to discuss the key
things that we must address when the study data are
released." One researcher stated that, "since the forums, I
have had contact with a number of people in several prov-
inces... and mostly, the contact is around questions about
the nature of the study and when it is going to appear.
Sometimes specific questions about the kinds of informa-
tion that will be reported arose."
The forums clearly helped to bring CAES (and patient
safety more generally) into stakeholder consciousness,
and onto "people's mental agenda if not on their organi-
zation's agenda" (researcher, following the first forum).
Data suggest the forums went even further than con-
sciousness-raising and helped to create some sense of
urgency for action in the area of patient safety, "The aim
[of the forum] was to say to those of us involved in patient
safety to beware and prepared so that we won't be shocked
when the data come out... to sensitize us and get someImplementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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preparation." Another stakeholder stated that, "I think the
importance of this forum is that it was really based on
introducing the Baker-Norton study [CAES] and the fact
that it's a reality, it's going happen, we are going to have
data and, for us, I guess, the urgency of dealing with our
own responses and potential activities became more of a
reality" (stakeholder, following the first forum).
Forums promoted less instrumental research utilization
In addition to the informational, consciousness-raising
impact of the CAES forums described above, the architects
of the CAES forums were interested in promoting a some-
what more proactive, instrumental use of CAES research.
Following the first forum, one of CAES/forum sponsors
suggested that, "At future meetings we could get the stake-
holders to give a synopsis re strategies their organizations
are taking around adverse events with the aim of making
it their agenda where we become players in a forum of
affected people." However, as one stakeholder stated fol-
lowing the second forum, "The original intent [of the
forum] was to help prepare stakeholders for a coordinated
response... I'm not sure we ever got there. I think that may
have been a lot to expect... we never even got to any coor-
dinated communication strategy." Interviewees were
asked about new and ongoing patient safety initiatives
and the extent to which these initiatives were driven by
the forums. Consistent with the data already described,
responses suggest the forum approach was useful for get-
ting CAES on the agenda of a wide range of Canadian
stakeholders, and perhaps facilitating other safety initia-
tives rather than creating them, "I think that the forums
have been sort of a starting point, there have been other
initiatives and other concerns that we have been able to
put forward and go maybe faster with because of this.
Would we be at the same point today? Probably not.
Would we be going down that route? Probably. So it's
been a valid contributor to the speed at which we have
taken things" (stakeholder, following the second forum).
Meeting the needs of decisionmakers was challenging
One of the most prominent themes, identified by stake-
holders and researchers following the first forum, was that
the objectives of the forum were not well understood. As
one stakeholder stated, "I don't think the objectives were
clear. We all went with mixed messages. There has been so
much discussion of patient safety that people probably
went expecting different things... mid-morning I pulled
out my invitation and had to read it again." This theme is
important as we try to understand what decisionmakers
want or, perhaps more pointedly, feel they need from this
type of interaction. The perceived lack of clarity of the
forum objectives may reflect the challenges associated
with convening an exchange forum where there are sev-
eral different types of stakeholders, not to mention
researchers and sponsors, each with their own priorities.
In the face of unclear objectives, our interviews revealed
that the methodologists came to the forum looking for
input into the study methodology while stakeholders rep-
resenting health service executives and health facilities
came hoping to obtain direction and tools for addressing
patient safety problems.
The second forum was more clearly aimed at showcasing
the patient safety initiatives and challenges of visible
stakeholders like the Canadian healthcare accreditation
body, Canadian Medical and Nursing Associations, and
other key stakeholders, as well as helping organizations
develop a media response to the CAES results. The media
session included a presentation featuring one organiza-
tion's media experience with a critical health related issue,
and was followed by breakout groups designed to identify
target audiences for a communication plan, outline key
messages, etc. Our interview data, along with data from a
small number of completed forum evaluations and our
observations of the second forum suggest that people did
not feel able to take away tools or strategies for addressing
adverse events, and the media preparedness component
of the second forum was not widely seen as valuable. Con-
sistent with the literature [1,16], nearly all stakeholders
expressed an interest in receiving interim study results
before the final release, even though it was made clear that
would not be possible given prior agreements between the
CAES researchers, forum funders, and the Canadian Med-
ical Journal (CMAJ) that had agreed to fast track peer
review and publication of the study results.
Our data indicate that stakeholders want "just-in-time"
data and operate on different timelines than the research-
ers or the forums [42]. The bulk of the exchange activity
took place during the first two forums, held two years and
one year prior to the release of the CAES results. The two
web conferences, which lasted approximately an hour and
provided only brief study updates, were held four months
and one month prior to release. Stakeholders were most
interested in release of the results and felt that there was
too much time between the forums and release. Following
the first forum, one stakeholder stated, "We're not ready
yet to hear what you want to tell us in terms of the next
step, we've got a million other issues that are before us,
this [CAES] will become an issue when we're much closer
to it hitting the media... until then our members aren't
ready to hear it and we have other priorities." Finally,
stakeholders were also clear in their interest for more fol-
low-up and direction at the time of data release. Similarly,
members of the research team felt this would be benefi-
cial, "If there was another forum, it should be about
implications or meaning of the results. What does it
mean? What should we do? Implications around actions,
maybe propose/present what other jurisdictions (UK,
Australia, etc) have done with results and how they haveImplementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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improved patient safety based on the results of this study.
It would be helpful for managers to know what the data
mean and what to do with it."
Despite this seemingly high degree of unmet need, stake-
holders reported that they would continue to attend or
take part in additional forums or web conferences related
to CAES. Indeed, the number of stakeholders showing
continued interest in CAES and the forum process rose
throughout the forum initiative, with 36 organizations
represented at the first forum, 62 at the second forum and
an even higher number on the two subsequent web con-
ferences.
Discussion
The knowledge translation forums and web conferences
we studied were perceived to be successful at providing
information about CAES and focusing stakeholders' atten-
tion on patient safety and rates of adverse events in Cana-
dian hospitals. The forums also seemed to stimulate
discussion and awareness, and help prepare a key group of
national stakeholders to, in some way, receive what were
certain to be highly sensitive study results. This was
accomplished in a positive light by highlighting that sys-
tem changes would be the likely target for change in
response to the study. Finally, the forums created some
sense of urgency around addressing patient safety issues.
The forums were seen as less successful at helping stake-
holders prepare for media queries emerging from CAES,
stimulating any kind of unified or proactive response to
the results, or aiding stakeholders with study interpreta-
tion or next steps that could be used to try to reduce rates
of adverse events and improve patient safety. These find-
ings were consistent for a variety of stakeholders working
in different health related and policy settings. Broadly, our
results are consistent with the ideas that research and
knowledge produce multiple effects rather than a single
effect [11].
If we return to the three ways in which research can be
'used', where instrumental use involves concrete applica-
tion of research findings to make specific decisions or
changes, conceptual use has to do with changing people's
way of thinking) [9], and symbolic use reflects political
uses of research findings [10], our data suggest that the
forums had more of a 'conceptual' and 'symbolic' impact
than the 'instrumental' impact that was the primary aim of
the forums. Judged against literature that suggests it is
important to move beyond looking at narrow, instrumen-
tal uses of research [8], and literature arguing that concep-
tual and symbolic uses for research are indeed an
important and empirically demonstrated aspect of
research utilization [32], the forum approach we studied
seemed to have a positive impact. Similarly, if research is
seen not as a product for problem-solving, but "a process
of argument or debate to create concern and set the
agenda" [43], our results suggest that despite their short-
comings the forums may have successfully helped to
shape decisionmaker values and stance toward safety and
adverse events, thereby allowing decisionmakers to see
these potentially threatening study data as constructive,
rather than destructive. These effects are important
because for research to have an impact it must be consist-
ent with decisionmakers' values [17,43]. That said, from
the perspective of improving quality and safety, there
remains a clear need to move further and faster with sub-
stantive changes and improvements in this critical area of
improving patient safety.
Consistent with the literature on interaction approaches
to research and knowledge utilization, the more social,
face-to-face, interactive aspects of the forums had a posi-
tive impact, albeit predominantly conceptual and sym-
bolic, on stakeholders in terms of propelling them in the
direction of patient safety. Also consistent with the litera-
ture, our data suggest that the impact of the forums might
have been strengthened (and perhaps more instrumen-
tal), had the exchange process been extended beyond
release of the study results in a way that would have
brought stakeholders and researchers together to interpret
the results and discuss next steps for addressing patient
safety problems. Indeed, as noted in our review of the lit-
erature, this joint interpretation aspect is seen as a critical
component of the interaction approach to research utili-
zation [4,5,15]. Future endeavors to bring researchers and
decisionmakers together should ensure that interactions
include interpretation of the study results, particularly for
studies where the results may be more tacit [44], and
direction for action may not be immediately clear or obvi-
ous from the study findings.
Implications for interaction in knowledge translation
Our results contribute to the knowledge translation litera-
ture by suggesting some conditions under which various
interactive approaches to research utilization may be
more or less successful. For instance, our findings are not
consistent with literature stating that early and prolonged
contact between researchers and decisionmakers is critical
for successful research utilization [15,18,19,29]. Instead,
our case analysis encourages us to consider whether, for
studies with multiple stakeholders, fixed methods (e.g.,
replication studies) or highly public or politicized find-
ings, interaction approaches that focus around the latter
part of the study period and release of the study results
may be more appropriate and effective. Each of these
research attributes (multiple stakeholders, fixed methods,
high public interest) on its own, or together, may require
more targeted interactions that do not necessarily span the
length of the research process–multiple stakeholders may
have competing or inconsistent priorities that may com-Implementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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plicate an already challenging exchange process; fixed
questions and methods characteristic of replication stud-
ies leave no room for decisionmaker input into early
aspects of research; and highly publicized studies are
likely to attract interest regardless of whether there was
prior involvement in the process.
This case study raises several questions and, in doing so,
points out the need for research that further addresses
questions of: when and under what conditions decision-
maker involvement in research is warranted; and, where it
is warranted, under what conditions is involvement most
appropriate for various stages of the research process. As
Ross et al. note, there is a need "to be strategic about
involving decisionmakers in the research process... a one-
size-fits-all approach holds little chance of success... pick-
ing and choosing whether and how to involve decision-
makers", among other things, is a critical step in the
process [2]. The differing timeframes within which
researchers and decisionmakers operate that came
through in our data, and the fact that many research stud-
ies run longer than an organization's strategic plan and
the average decisionmakers' tenure, further underscore
the need to be efficient and strategic when it comes to
planning researcher-decisionmaker interactions.
The current case study also leads us to question whether
and/or when there has to be pre-existing concordance in
researcher and decisionmaker interests that is often cited
in the literature [16]. Indeed, it is possible that with highly
public studies, the nature of the study itself, together with
a broad based forum process (strategically designed to
address concerns, allay fears, and promote a productive
response), may actually bring about alignment of
researcher – decisionmaker interests. In the case of CAES,
by researching a highly politicized topic such as adverse
event rates in Canadian hospitals, the researchers seemed
to help set a common agenda and focus on this area. A
year after the release of the CAES results, a Canadian cam-
paign to intervene to reduce adverse events was under-
taken by some of the CAES investigators. Decisionmakers
in hospitals and health regions from across Canada have
signed up for the campaign en masse, committing substan-
tial organizational resources to improving patient safety
in certain areas [45]. Of course it is also possible that, for
the case we studied, this alignment of researcher – deci-
sionmaker interests around patient safety was facilitated
by other high-profile patient safety reports, starting with
the Institute of Medicine reports, To Err is Human [46]
and Crossing the Quality Chasm [47] in addition to CAES.
Finally, we question whether interaction can successfully
align unaligned interests, or resolve value conflicts
between decisionmakers and researchers, as the interac-
tion model implies. These kinds of barriers to research uti-
lization are not only pervasive but often insurmountable,
even when there has been prolonged interaction [22].
Decisions concerning the value of interaction need to take
account of the nature, goals, and potential of the interac-
tion, if interaction is going to be useful in complex
research and practice contexts.
So, in addition to the three models of decisionmaker
involvement (formal support, responsive audience, and
integral partner) articulated by Ross et al. [2] and noted in
the literature section, the current case study suggests a
fourth model of decisionmaker involvement for consider-
ation and future research called "intermittent partner"
(particularly for preparation for use of results). In terms of
the four factors that Ross et al. [2] suggest influence the
decisionmaker's role (stage of research process, time com-
mitment required, alignment between decisionmaker
expertise/research program, presence of an existing rela-
tionship), we propose further exploration of a fifth factor
that might influence the decisionmaker's role that has to
do with the nature or attributes of the research topic and
findings. Future research could test whether the four
attributes illuminated by the current case study – stake-
holder diversity, addressability/actionability of results,
finality of study design and methodology, and politiciza-
tion of result – or other attributes, can be used to specify
some of the conditions under which different approaches
to interaction in knowledge translation are likely to facil-
itate research utilization (instrumental, conceptual and/or
symbolic). For instance, stakeholder diversity may be an
important moderator variable such that interaction proc-
esses may explain a significant amount of variation in
instrumental research utilization under conditions of low
stakeholder diversity, but not under conditions of high
stakeholder diversity (perhaps because a homogeneous
stakeholder group permits greater focus on a small
number of highly relevant issues germane to the study and
to implementation of change by that group). Another
example may be that studies with politicized results mod-
erate the relationship between sustained interaction and
conceptual research utilization where, under conditions
of high politicization, this relationship is more signifi-
cant. Additional research on these and other questions,
that uses different research designs would contribute to
greater understanding of the relationship between interac-
tion processes and the outcome of research utilization,
including potential moderator variables.
Broader implications for knowledge translation research
Even studies with discrete outcomes, such as a systematic
review of the effectiveness of a specific treatment in a cer-
tain clinical situation, face considerable challenges when
it comes to successful knowledge transfer and uptake
[48,49]. Our case study examined a knowledge translation
effort for research with broad implications, multiple targetImplementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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audiences, and potentially inflammatory results that
underlined the need for change, but offered no clear direc-
tion for achieving it. Our analysis suggests that the
response to this startling data (by extrapolation the CAES
data showed that somewhere between 9,000 and 24,000
deaths from adverse events could have been prevented in
Canadian hospitals in the year 2000 [34]) was at most
symbolic and conceptual.
It is clear that in the face of evidence, pervasive barriers to
change exist in the contexts of clinical, policy, and organ-
izational decision-making. The barriers are often different
in each of these arenas, but include traditions of auton-
omy, politics and values, competing priorities, perverse
financial incentives, and lack of knowledge of what and
how to change, respectively. This situation further under-
scores the need for additional research in the area of
research utilization. A theory of research utilization must
continue to look beyond interaction approaches and also
consider models of change. For instance, the organiza-
tional literature suggests that the kind of incremental
change that is inherent in current interaction models, by
and large, fails to lead to any meaningful organizational
reorientation because incremental change is not forceful
enough to overcome cognitive and motivational inertia
[50,51] or the stabilizing effects exerted by scientific com-
munities. Incorporating more radical models of change
[52] from the organization arena into a theory of research
utilization may bode well for expediting scholarly work in
this important area.
Work on research utilization in healthcare might also do
well to draw on work in the organizational literature on
learning capacity. This work focuses on the user context
and the ability to recognize the value of new knowledge
and apply it in the organization [53]. Though a focus on
learning capacity may seem reminiscent of the older, now
abandoned research pull models and certain elements of
the dissemination model [14], it may be fruitful to revisit
some of the promising levers for change that may exist in
both the researcher and user contexts, in addition to fur-
ther examining the sphere of researcher-decisionmaker
interaction and research utilization more broadly. It may
also be instructive to revisit the work of Argyris and col-
leagues [54] concerning action science and Torbert's more
recent work on action inquiry [55]. This work links learn-
ing capacity to a well-established participatory action the-
ory and might strengthen current interaction models in
research utilization.
Finally, it is important to address not just the inherent
plausibility and demonstrated validity of research utiliza-
tion theory, but the circumstances in which it may or may
not be applicable. There are important counter-examples
to the voluntary and incremental theory of change in
health care, e.g., the transformations of the National
Health Service in the UK and the Veterans Affairs health
system in the US, and changes in use of hormone replace-
ment therapy in menopausal women. The latter was
largely research-driven but did not involve early-stage or
sustained interaction among researchers and decision-
makers; in fact the decisionmakers were as much the pub-
lic as their physicians. In the former two cases, the change
was policy-driven and mandated, and accompanied by
structures and lines of authority that greatly accelerated
the pace of reform. A full account of how major and rapid
change occurs would both refine the theory of research
utilization and an understanding of where it is central or
tangential to improvement, and where and when other
options present better alternatives.
The strengths and limitations of this study are, to some
degree, tied up with the strengths and weaknesses of the
knowledge translation effort we studied. For instance, one
strength of the forum approach is that it targeted stake-
holders at several levels of the health care system, and in
doing so, recognized the importance of the organizational
environment, social, regulatory, and other contexts in the
research translation process [56-58]. In parallel, one
strength of our study is that we were able to look at the
impact of a knowledge translation effort that took context
into account. A limitation of the approach we studied lies
in its failure to sustain interaction at what decisionmakers
saw as the most critical juncture of the study–the release
and interpretation of the results and discussion of next
steps. Correspondingly, we were unable to look at the
impact forum interactions might have had, had they been
carried out in these important latter stages of CAES. An
additional limitation of this study has to do with our ina-
bility to more fully examine the different perceptions and
expectations of stakeholders versus researchers, including
the extent to which these differing perspectives may be
important determinants of successful interaction.
Conclusion
Current interaction theory proposes early and sustained
interaction between researchers and decisionmakers as
mechanisms for improving research utilization. The cur-
rent study adds to this literature by raising questions
about whether there are some conditions under which full
scale interaction and decisionmaker involvement in
research will be more or less effective. Future research
could test whether four attributes illuminated by the cur-
rent case study (stakeholder diversity, addressability/
actionability of results, finality of study design and meth-
odology, and degree of politicization of results) can be
used to specify some of the conditions under which differ-
ent approaches to interaction in knowledge translation
are likely to facilitate research utilization. This study
examined a knowledge translation effort in its naturalImplementation Science 2007, 2:34 http://www.implementationscience.com/content/2/1/34
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context. We were fortunate to be able to focus on the inter-
action component of research utilization, a component
which we suggest requires further exploration. We were
able to examine a knowledge translation effort that
required complexity in order to manage the fact that CAES
would be highly publicized, and the results would war-
rant change at so many levels. These complexities help us
to suggest certain conditions under which more targeted
researcher-decisionmaker interactions may be most effec-
tive. These complexities also enable us to see the value in
extending our search so we can specify a broader theory of
research utilization that accounts for the slow pace of
change in this area.
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